2009Anhui Medical and Pharmaceutical JournalRequires access

The value of multi-tumor markers protein chip diagnosis system in the differential diagnosis of benign and malignant pleural effusion and ascites

Zhendong Chen

Open publisher page 0 citations

Abstract

Aim To explore the reliability and validity of C12 system for the differential diagnosis of benign and malignant pleural effusion and ascites.Methods The levels of twelve tumor markers of pleural effusion and ascites were measured.Meanwhile,the diagnostic criteria were compared with the cytology of pleural effusion and ascites.Results The levels of CEA,Ferrtin,CA153 and CA125 of malignant pleural effusion group were remarkably higher than those of the benign group(P0.01).The levels of CEA,Ferrtin,CA199,CA242 and CA125 of malignant ascites group were remarkably higher than those of the benign group(P0.01).Different cancers always have different tumor markers.The coincident rate of C12 system was 83.78%,81.82% and 83.75% respectively when the result of cytology was positive,doubt and negative respectively.Conclusion Multi-Tumor Markers Protein Chip diagnosis System is helpful to the differential diagnosis of benign and malignant pleural effusion and ascites.Compared with the detection of single tumor marker,it can increase the diagnostic specificity of malignant pleural effusion and ascites.

About this research paper

What this paper is about

Aim To explore the reliability and validity of C12 system for the differential diagnosis of benign and malignant pleural effusion and ascites.Methods The levels of twelve tumor markers of pleural effusion and ascites were measured.Meanwhile,the diagnostic criteria were compared with the cytology of pleural effusion and ascites.Results The levels of CEA,Ferrtin,CA153 and CA125 of malignant pleural effusion group were remarkably higher than those of the benign group(P0.01).The levels of CEA,Ferrtin,CA199,CA242 and CA125 of malignant ascites group were remarkably higher than those of the benign group(P0.01).Different cancers always have different tumor markers.The coincident rate of C12 system was 83.78%,81.82% and 83.75% respectively when the result of cytology was positive,doubt and negative respectively.Conclusion Multi-Tumor Markers Protein Chip diagnosis System is helpful to the differential diagnosis of benign and malignant pleural effusion and ascites.Compared with the detection of single tumor marker,it can increase the diagnostic specificity of malignant pleural effusion and ascites.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To explore the reliability and validity of C12 system for the differential diagnosis of benign and malignant pleural effusion and ascites.Methods The levels of twelve tumor markers of pleural effusion and ascites were measured.Meanwhile,the diagnostic criteria were compared with the cytology of pleural effusion and ascites.Results The levels of CEA,Ferrtin,CA153 and CA125 of malignant pleural effusion group were remarkably higher than those of the benign group(P0.01).The levels of CEA,Ferrtin,CA199,CA242 and CA125 of malignant ascites group were remarkably higher than those of the benign group(P0.01).Different cancers always have different tumor markers.The coincident rate of C12 system was 83.78%,81.82% and 83.75% respectively when the result of cytology was positive,doubt and negative respectively.Conclusion Multi-Tumor Markers Protein Chip diagnosis System is helpful to the differential diagnosis of benign and malignant pleural effusion and ascites.Compared with the detection of single tumor marker,it can increase the diagnostic specificity of malignant pleural effusion and ascites.

Key concepts: Ascites, Pleural effusion, Medicine, Differential diagnosis, Malignant pleural effusion, Cytology, Effusion, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
The value of multi-tumor markers protein chip diagnosis system in the differential diagnosis of benign and malignant pleural effusion and ascites — Research Paper | ScholarLens